Biofil Chemicals & Pharmaceuticals Ltd. logo

Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM)

Market Open
10 Aug, 10:00
XNSE XNSE
32. 64
+0.25
+0.7718%
1.02B Market Cap
- P/E Ratio
- Div Yield
9,809 Volume
- Eps
32.39
Previous Close
Add Transaction
Day Range
32.12 33.61
Year Range
25.6 46.34
Want to track BIOFILCHEM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BIOFILCHEM trading today higher at ₹32.64, an increase of 0.7718% from yesterday's close, completing a monthly decrease of -8.954% or -₹3.21. Over the past 12 months, BIOFILCHEM stock lost -3.7736%.
BIOFILCHEM is not paying dividends to its shareholders.
The last earnings report, released on May 30, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

BIOFILCHEM Chart

Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) FAQ

What is the stock price today?

The current price is ₹32.64.

On which exchange is it traded?

Biofil Chemicals & Pharmaceuticals Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is BIOFILCHEM.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.02B.

Has Biofil Chemicals & Pharmaceuticals Ltd. ever had a stock split?

No, there has never been a stock split.

Biofil Chemicals & Pharmaceuticals Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Ramesh S. Shah CEO
XNSE Exchange
Y0894B115 CUSIP
India Country
26 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Biofil Chemicals and Pharmaceuticals Limited, established in 1985, operates within the pharmaceutical and chemical sectors primarily in India. With a base in Indore, India, the company has carved a niche in the industry by offering a broad spectrum of basic drugs and chemicals, alongside niche products such as plastic dippers and caps. Biofil not only focuses on the production and distribution of these products but also extends its expertise to provide job work services for the manufacturing of pharmaceuticals. This reflects the company’s adaptability and commitment to catering to the varied needs of its clientele in the healthcare sector.

Products and Services

Biofil Chemicals and Pharmaceuticals Limited's product lineup includes:

  • Sodium Chloride, Potassium Chloride, Sodium Citrate: Basic yet essential drugs used in medical treatments. These compounds are fundamental in various pharmaceutical formulations, ensuring wide applicability in healthcare.
  • Diethyl Carbamazine Citrate: This anti-parasitic drug is specifically used to treat filariasis and other parasitic infections, showcasing Biofil’s contribution to combating parasitic diseases.
  • Ferrous Sulphate, Dried Ferrous Sulphate, Ferrous Fumerate: These iron supplements play a crucial role in treating iron deficiency anemia. The range of iron salts indicates Biofil's dedication to addressing global health issues like anemia.
  • Micro Crystalline Cellulose: A widely used excipient for pharmaceutical formulations. Its inclusion in Biofil's product portfolio highlights the company's role in facilitating drug manufacturing.
  • Dicyclomine Hydrochloride: Employed to treat symptoms of irritable bowel syndrome, demonstrating Biofil's engagement in producing drugs that improve gastrointestinal health.
  • Plastic Dippers and Caps: Apart from chemicals and drugs, Biofil also manufactures plastic components for pharmaceutical packaging, reflecting its diversified approach in serving the pharmaceutical industry.

In addition to these products, Biofil offers:

  • Job Work Service for Manufacturing of Pharmaceuticals: This service enables other pharmaceutical companies to leverage Biofil’s manufacturing capabilities, underscoring its collaborative approach within the industry.

Contact Information

Address: 11/12, Sector 'E'
Phone: 91 73 1272 3016